StockData
Elutia Inc. logo

Elutia Inc. (ELUT) bonds

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/307% below fair value
$0.85+0.03 (+3.77%)

Close on Nov 17, 2026Market cap $37.82MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Elutia reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2021

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Elutia's 10-Q for the period ended Jun 30, 2025

Elutia's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed. The repayment schedule above comes from the same report.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeDrawn
New Asset-Based Revolving Loan Facility$8.00M–
SWK Loan Facility$25.00M$23.90M
SWK Loan Facility-Term Loan$5.00M–

See a number that looks wrong?